Maitreya Medicare Share Price

Maitreya Medicare Limited was originally incorporated as Maitreya Medicare Private Limited at Surat Gujarat, vide a Certificate of Incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC). Thereafter, name of the Company was changed to Maitreya Medicare Limited and a fresh Certificate of Incorporation was issued by the RoC on March 30, 2023. Since then, Company engages in providing healthcare services and products. The Company was founded by Dr. Narendra Singh Tanwar, an eminent and highly skilled cardiologist who has more than 20 years of experience in healthcare industry. The Company is a growing organization that aims at strengthening and establishing itself as foremost healthcare services provider. It has a team of medical practitioners who ensures that patients get the quality healthcare services. The Companys healthcare staff members comprise of Unit Head, Consultant Doctors, Clinical Pharmacist, XRay Technician, Medical Officers, Clinical Assistants, Medical Executives, OT Assistant, Infection Control Nurse, Other Nursing Staff, Attendants, Maintenance Head, Dietician /Nutritionist etc. Also, the Company is associated with several organizations for providing regular healthcare checkup facilities to their employees at affordable rates. The Companys healthcare facilities consist of advanced technology and our doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards. Company provide inpatient and outpatient healthcare services through its hospitals at Surat, Mumbai, Valsad and Nandurbar (Maharashtra), with an aggregate bed capacity of 550 beds. In 2019, the Company commissioned their first commercial operations at Surat Hospital, in Gujarat. It expanded for B Wing and converted into 125 beds from 100 beds in 2021.The Hospitals core specialities are Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology HighRisk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.Their healthcare facilities consist of advanced technology and doctors, nurses and other healthcare professionals follow treatment protocols that match acceptable standards. The hospital boasts of one of its kind premier Cathlab, two modular superspeciality operation theatres with laminar air flow and HEPA filters, well equipped 20 bedded Intensive Care Units (ICU) with ECMO and CRRT and excellent support services like Pathology and Radiology including CT scan. This unit has the potential to expand further by 75 beds to make it 200 bed structure with quaternary care facilities like Organ Transplants, Robotics in near future.In November 2023, Company launched the IPO by issuing 18,16,000 equity shares of Rs 10 each and raised a fresh issue of 14.89 crores.

For the full year FY2025–2026, revenue reached ₹47.23 crore and profit touched at ₹1.87 crore.